Medical Genetics For Students: Pedigrees, Inheritance And Testing

Medical genetics for students often feels like learning a second language: symbols, patterns, probabilities and a vocabulary that changes quickly. This guide walks you through the three skills that matter most in practice — building and reading a pedigree, recognising the main inheritance patterns, and choosing the right genetic test — with worked examples you can reuse in exams and on the wards.

Why Medical Genetics Belongs in Everyday Clinical Practice

Genetics is no longer a niche specialty. It now sits behind cardiology, oncology, paediatrics, obstetrics, neurology and primary care.

Almost every clinician will order a genetic test, interpret a family history, or refer a patient for counselling at some point.

Family history is a screening tool. A careful pedigree can flag risk before any laboratory test is ordered.
Testing has become cheaper and broader. Panel, exome and genome testing are now routine in many services.
Results change management. A confirmed diagnosis can alter surveillance, treatment and reproductive options.
Ethics are built in. Consent, confidentiality and family implications are part of every genetics consultation.
Exams love it. Inheritance patterns and risk calculations appear in almost every clinical assessment.

Genetics is not only about rare diseases; it is about how every disease risk is distributed in families.

Reading a Pedigree: The Core Skill

A pedigree is a structured family tree. It converts a messy conversation into a standard diagram that any clinician can read.

Standard Pedigree Symbols

Learn these symbols once and you will use them for the rest of your career.

Square — male.
Circle — female.
Diamond — sex unspecified or unknown.
Filled (shaded) symbol — affected by the condition in question.
Empty symbol — unaffected.
Dot in the centre — known carrier.
Horizontal line — mating or partnership.
Vertical line dropping from a mating line — offspring.
Diagonal line through a symbol — deceased.
Double horizontal line — consanguineous union.
Arrow — the proband, the person who first brought the family to attention.

Generations, Numbering and Annotations

Convention matters because it lets you describe a relative precisely and without confusion.

Generations are labelled with Roman numerals from the top: I, II, III, IV.
Individuals within a generation are numbered left to right with Arabic numerals.
The proband is marked with an arrow and is usually written as II-3 or III-1.
Age, age at diagnosis and age at death are added below the symbol where relevant.
Ethnic background, consanguinity and pregnancy losses are recorded beside the pedigree.
If the history is uncertain, write what the family reported and note that it is unverified.

What to Ask While You Draw

Has anyone in the family had the same condition, or something that sounds similar?
At what age did symptoms start, and how severe were they?
Any sudden deaths, unexplained deaths, or deaths in infancy?
Any history of recurrent miscarriages, stillbirths or infertility?
Any learning difficulties, developmental delay or congenital anomalies?
Any cancers, and if so, what type and at what age?
Are the parents related by blood?
Which relatives have already had genetic testing?

Common Mistakes to Avoid

Accepting a family report of a diagnosis without asking whether it was genetically confirmed.
Assuming an unaffected parent cannot carry a pathogenic variant.
Missing half-siblings and children from previous relationships.
Forgetting to record which side of the family the condition comes from.
Drawing the pedigree once and never updating it — families change and information evolves.

Patterns of Inheritance You Must Recognise

Five patterns cover the majority of cases you will see in clinics and in exams.

Pattern	Typical pedigree clue	Example recurrence risk	Practical catch
Autosomal dominant	Vertical transmission, affected in every generation, males and females equally affected	50% for each child of an affected parent	Reduced penetrance and variable expressivity can hide affected relatives
Autosomal recessive	Horizontal pattern in one sibship, unaffected carrier parents, consanguinity	25% for each child of two carriers	Carrier frequency differs between populations
X-linked recessive	Affected males, carrier females, no male-to-male transmission	50% of sons affected if the mother is a carrier	Skewed X-inactivation can make carrier women symptomatic
X-linked dominant	Affected father transmits to all daughters and no sons	50% of children of an affected mother	Often more severe in males
Mitochondrial	Affected mothers transmit to children of both sexes; affected fathers transmit to none	Highly variable	Heteroplasmy and threshold effects make prediction difficult

Autosomal Dominant Inheritance

The condition appears in every generation, though new mutations can appear for the first time.
Each child of an affected parent has a 50% chance of inheriting the variant.
Males and females are affected in roughly equal numbers.
Penetrance describes the proportion of carriers who show any features at all.
Expressivity describes how severely an affected person is affected.
Classic teaching examples include Huntington disease and Marfan syndrome.

Autosomal Recessive Inheritance

Parents are usually unaffected carriers, so the family history may look empty.
Two carriers have a 25% chance of an affected child, a 50% chance of a carrier child, and a 25% chance of an unaffected non-carrier child with each pregnancy.
Consanguinity increases the chance that both parents carry the same rare variant.
Affected siblings in the same generation is a classic horizontal pattern.
Examples include cystic fibrosis, sickle cell disease and beta-thalassaemia.
Carrier screening can be targeted when the family variant is already known.

X-Linked Inheritance

Hemizygous males express a pathogenic variant on their single X chromosome.
Affected males cannot pass an X-linked variant to their sons, because they give sons a Y chromosome.
All daughters of an affected male are carriers of an X-linked recessive variant.
Carrier females may be fully healthy, mildly affected, or occasionally severely affected.
Examples include haemophilia A and Duchenne muscular dystrophy.

Non-Classical and Complex Patterns

Imprinting — expression depends on which parent contributed the variant.
Anticipation — earlier onset or greater severity in successive generations, seen in repeat expansion disorders.
Germline mosaicism — a parent without the variant in blood may still have affected children.
Multifactorial traits — many genes plus environment, producing clustering rather than clear patterns.
De novo variants — a new variant in the affected person with no family history.

A pedigree suggests a pattern; it never proves one. Confirmation comes from clinical assessment and carefully chosen testing.

From Pedigree to Risk: A Worked Example

Two healthy parents have a son with a recessive metabolic disorder. Neither has a family history, and the parents are not related.

Step 1: Both parents are assumed to be carriers, because the condition is recessive and there is no other affected relative.
Step 2: Each future child has a 25% risk of being affected, 50% of being a carrier, and 25% of being neither.
Step 3: Testing the child first confirms the diagnosis and identifies the exact variants.
Step 4: Testing the parents confirms carrier status and allows accurate counselling.
Step 5: The unaffected sibling’s risk depends on the parents’ carrier status and can be refined by testing.

Notice that the risk figure never changed the diagnosis. It only described probability before testing was available.

Genetic Testing Options for Students

Choosing a test is a clinical decision, not a shopping decision. The right test answers a specific question.

Karyotype — looks at chromosome number and large structural changes.
Fluorescence in situ hybridisation — targeted detection of a known region or microdeletion.
Chromosomal microarray — first-tier test for developmental delay, congenital anomalies and copy number changes.
Targeted variant testing — checks one or a few known familial variants, ideal for cascade testing.
Gene panel — sequences many genes linked to one clinical presentation, such as hereditary cancer or cardiomyopathy.
Exome and genome sequencing — broad approaches used when the phenotype is unusual or the differential is wide.
Repeat expansion testing — specific assays for disorders caused by nucleotide repeats.
Prenatal and preimplantation testing — used when a familial variant is already known.

Diagnostic, Predictive and Carrier Testing

Diagnostic testing is done in a person with symptoms to confirm or exclude a condition.
Predictive testing is done in a healthy person with a known family variant, often for adult-onset conditions.
Carrier testing identifies people who could pass a recessive or X-linked variant to their children.
Cascade testing offers targeted testing to relatives of a confirmed carrier or affected person.
Pharmacogenomic testing guides drug choice and dosing rather than diagnosing disease.

Interpreting Results Without Overreading Them

Pathogenic or likely pathogenic — supports a diagnosis, but the clinical picture must still fit.
Variant of uncertain significance — a change we cannot currently classify; it is not a diagnosis.
Likely benign or benign — usually considered normal variation.
Negative result — reduces but never fully removes the possibility of a genetic cause.
Secondary findings — unrelated medically actionable variants that may be reported with consent.

Practical Pitfalls in Test Selection

Ordering a broad test before a targeted one when the familial variant is already known.
Testing without confirming the family variant, which can make results uninterpretable.
Forgetting to check that the requested test includes the gene you actually care about.
Ignoring the sample type required, such as blood, saliva or a tissue sample.
Overlooking the turnaround time when a result is needed urgently.

Communication, Consent and Ethics

Genetics results rarely belong to only one person. They often carry meaning for parents, siblings and children.

Explain what a test can and cannot tell the patient before the sample is taken.
Discuss possible unwanted findings, including secondary findings and uncertain results.
Be clear about who else may need to be informed after a confirmed result.
Respect confidentiality while recognising that relatives may have a legitimate interest.
Offer referral to a genetic counsellor for complex, emotional or reproductive decisions.
Use plain language and check understanding rather than assuming it.

Study Strategies for Medical Genetics

Students who do well in genetics usually practise patterns, not memorisation.

Draw at least twenty pedigrees from textbook cases until the symbols become automatic.
Practise identifying the pattern before you look at the answer.
Learn one classic example per inheritance pattern and build outward from it.
Calculate a recurrence risk every time you read a case vignette.
Write short summaries linking a pattern to a testing strategy and a counselling point.
Discuss real cases with a genetic counsellor if your programme allows it.
Revise terminology such as penetrance, expressivity and mosaicism regularly, because they appear constantly.

Conclusion

Medical genetics for students becomes manageable once you separate the three tasks: describe the family in a pedigree, propose the most likely inheritance pattern, and choose the test that confirms or refutes it. Practise the symbols, the risk arithmetic and the counselling language until they feel routine, and the subject turns from memorisation into structured clinical reasoning.

Frequently Asked Questions

What is a pedigree and why do I need one?

A pedigree is a standardised diagram of a family’s medical history across generations. It helps you spot inheritance patterns, decide which relatives are at risk, and choose an appropriate test. It is also a communication tool, because any clinician can read the same diagram.

How do I tell whether a pattern is autosomal or X-linked?

Look at two things: whether males and females are affected unequally, and whether any affected father has an affected son. X-linked recessive conditions affect males far more often and are never transmitted from father to son. If both sexes are affected in similar numbers with transmission through both parents, autosomal inheritance is more likely.

What does reduced penetrance mean?

Reduced penetrance means that some people who carry a pathogenic variant never develop any features of the condition. For example, two carriers of the same dominant variant may have very different outcomes, which is why a parent can appear completely unaffected yet still pass the condition on.

What is the difference between a carrier and an affected person?

A carrier has one copy of a recessive variant and usually has no symptoms, but can pass the variant to children. An affected person has two copies in autosomal recessive disease, or one copy in a dominant condition, and shows features of the disorder.

When should genetic testing be offered?

Testing is offered when the result is likely to change management, clarify a diagnosis, guide surveillance, or inform reproductive decisions. It should follow a conversation about benefits, limitations and possible unexpected findings. If the result would not change anything, testing is often unnecessary.

What is a variant of uncertain significance?

A variant of uncertain significance is a DNA change that has not yet been classified as harmful or harmless. It is not a diagnosis, and acting on it as though it were one can cause harm. Over time, extra evidence may allow reclassification in either direction.

Can two unaffected parents have a child with a genetic condition?

Yes. In autosomal recessive disease both parents are usually healthy carriers. A new dominant variant can also arise in the child for the first time, and a parent may carry a variant only in their reproductive cells, a situation known as germline mosaicism.

What is the difference between diagnostic and predictive testing?

Diagnostic testing is performed in someone who already has symptoms or features of a condition. Predictive testing is performed in a healthy person who has a known familial variant, to clarify their future risk. Predictive testing always requires careful counselling.

How do I calculate recurrence risk quickly in an exam?

Identify the pattern first, then apply the standard figure. Two carriers give a 25% risk per pregnancy, an affected dominant parent gives 50%, and a carrier mother of an X-linked recessive condition gives 50% of sons affected. Adjust for the sex of the child when the pattern is X-linked.

How much genetics do I actually need for clinical practice?

You need enough to take a solid family history, recognise the common inheritance patterns, choose a sensible test, and explain a result honestly. Deep molecular detail is useful, but the everyday skill is knowing when to test, when to refer, and how to communicate uncertainty.